Breeze Meds vs Embody
An in-depth comparison of two leading GLP-1 Providers
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Breeze Meds
Best for: knowing which pharmacy fills the vial — it names Belmar Pharmacy
Visit Breeze Meds →
Embody
Best for: knowing which pharmacy fills the vial — it names RedRock Pharmacy
Visit Embody →Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, Embody opens cheaper — $79/mo against $199, and Embody finishes ahead, 9.3 to 7.7. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.
Pricing
Breeze Meds
Displayed on rendered homepage card 'GLP-1 Injection / Starting at $199'. Checkout catalog JS shows monthly:199 with oldPrice:249 and bundles threeMonthly:748 / sixMonthly:1248 / yearly:2298 ($191.50/mo effective).
Homepage card displays 'Starting at $399'. The site's own checkout catalog (/_nuxt/tdPmVDYT.js) prices it monthly:299 with oldPrice:399 (bundles 1068/3mo, 1918/6mo, 3498/yr) — but checkout is intake-gated, so $299 was found in code, not rendered publicly; keep $399 as the published price and treat $299 as an unconfirmed in-checkout promo.
Rendered card 'Oral Semaglutide / Starting at $299 / One dissolvable tablet per day.' Catalog bundles: 899/3mo, 1799/6mo, 3498/yr.
Rendered card 'Oral Tirzepatide / Starting at $399 / One dissolvable tablet per day.' Catalog bundles: 1199/3mo, 2399/6mo, 4799/yr.
Embody
Checkout: '$79/mo flat forever' (strikethrough $299); bundles $76/$73/$69 per month on 3/6/12-mo. CAVEAT: T&C list price is $199/mo — the $79 depends on the auto-applied SUMMER promo marketed as permanently locked; Trustpilot complaints allege the lock was not always honored.
Checkout tile 'Flat rate at $119/month (strikethrough $349)'; homepage 'starting at $129/month'; bundles $126/$123/$119 per month.
New oral semaglutide $229/mo.
Oral tirzepatide $329/mo; gum bundles to $299/mo at 12-month.
What’s included
Breeze Meds
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Embody
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Score breakdown
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
Breeze Meds
7.7/10
Embody
9.3/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Features & Coverage
| Feature | Breeze Meds | Embody |
|---|---|---|
| Starting Price | $199/mo | ✓$79/mo |
| Features | 6 features | 6 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
About Breeze Meds
Breeze Meds is a Georgia-based telehealth seller shipping to all 50 states, with compounded semaglutide at $199/mo, tirzepatide at $399/mo, and NAD+ at $169/mo. It is LegitScript certified, names its medical team (Dr. Ana Lisa Carr MD and Dr. Kelly Tenbrink MD), and works through a 4-pharmacy compounding network via Lion MD: Belmar, Strive, Epiq Scripts, and Casa Pharma Rx.
Read our full Breeze Meds review →About Embody
Embody sells compounded semaglutide and tirzepatide by injection, plus a compounded oral tirzepatide gum that is unique in the category. Flat-rate pricing is aggressive, coverage runs to all 50 states, and clinician messaging is available 24/7 under a board-certified internal medicine CMO.
Read our full Embody review →Pros & Cons
Breeze Meds
What we like
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly figure covers medication and shipping
- Coverage is published for all 50 states
- Names 4 dispensing pharmacies, which most sellers in this register do not do
- No FDA warning letter matched this operator when we searched our enforcement register
- Both oral and injectable options are on record, so the format is a choice rather than a condition
Watch-outs
- Tirzepatide at $399 a month, 49% above the $267 register median for the same drug and form
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Embody
What we like
- Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
- Tirzepatide at $129 a month, 52% below the $267 median for the same drug and form across this register
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly figure covers medication, consult, shipping
- Coverage is published for all 50 states
- Names 4 dispensing pharmacies, which most sellers in this register do not do
- No FDA warning letter matched this operator when we searched our enforcement register
- Both oral and injectable options are on record, so the format is a choice rather than a condition
Watch-outs
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Embody takes it, 9.3 against 7.7, and it is especially strong on knowing which pharmacy fills the vial — it names RedRock Pharmacy. Breeze Meds is no weak second and may fit you better on knowing which pharmacy fills the vial — it names Belmar Pharmacy.
Choose Breeze Meds if…
You want knowing which pharmacy fills the vial — it names Belmar Pharmacy and an opening price near $199 a month.
Choose Embody if…
You want knowing which pharmacy fills the vial — it names RedRock Pharmacy and an opening price near $79 a month.
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Trimi Health
Knowing which pharmacy fills the vial — it names VialsRx
From $99/mo
Get started →Strut Health
Semaglutide at $99/month, 48% under the register median
From $99/mo
Get started →Oak
Semaglutide at $119/month, 37% under the register median
From $119/mo
Get started →Breeze Meds vs Embody: FAQ
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Breeze Meds and Embody head-to-heads in the same category.
- Breeze Meds vs Trimi Health
- Breeze Meds vs He & She MD
- Breeze Meds vs Lean Meds
- Embody vs NextMeds
- Embody vs bmiMD
- Embody vs CoreAge Rx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.